FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
Briefly

from ABC7 Los Angeles4 days ago
The FDA approved Vertex Pharmaceuticals' Journavx, a novel pain relief medication that eliminates the risks associated with traditional opioids, marking the first new method for pain management in over two decades. Targeted for short-term post-surgical pain, Journavx exhibits modest effectiveness compared to existing treatments. While it surpassed a placebo in trials involving over 870 patients, it does not outperform common opioid-acetaminophen combinations. Marketed at a high price point, this drug is rooted in attempts to address the ongoing opioid crisis, aiming to offer a safer alternative for pain management.
It's not a slam dunk on effectiveness, but it shows a lot of promise in a very different pathway and mechanism of action.
ABC7 Los Angeleshttps://abc7.com/post/fda-approves-painkiller-designed-eliminate-risk-addiction-associated-opioids/15850954/
Vertex's drug provides more relief than a dummy pill but didn't outperform a common opioid-acetaminophen combination pill.
ABC7 Los Angeleshttps://abc7.com/post/fda-approves-painkiller-designed-eliminate-risk-addiction-associated-opioids/15850954/
Read at ABC7 Los Angeles
#pain-management #opioids #fda-approval #vertex-pharmaceuticals #pain-relief
[
|
]